Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 0.82 |
| ▸ | RAB9A | P51151 | 4/20 | 0.82 |
| ▸ | MAOB | P27338 | 3/20 | 0.82 |
| ▸ | MAOA | P21397 | 2/20 | 0.82 |
| ▸ | ESR1 | P03372 | 1/20 | 0.82 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.82 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.82 |
| ▸ | POLB | P06746 | 1/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.81 |
| ▸ | MEN1 | O00255 | 3/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.81 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.81 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.81 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.81 |
| ▸ | PKM | P14618 | 1/20 | 0.81 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.81 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.81 |
| ▸ | RELA | Q04206 | 1/20 | 0.81 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25236411 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| SCHEMBL10703657 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| SCHEMBL10787169 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| SCHEMBL25211913 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| 4,4'-Dihydroxychalcone SCHEMBL773588 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| SCHEMBL25223420 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| 4,4'-Dihydroxychalcone SCHEMBL25202156 | 1.00 | F3 (1.00) | F3MAPTRAB9AMAOBMAOA | |
| SCHEMBL25208810 | 0.92 | F3 (0.85) | F3MAPTRAB9AMAOBMAOA | |
| SCHEMBL12651351 | 0.92 | F3 (0.85) | F3MAPTRAB9AMAOBMAOA | |
| 4,4'-Dihydroxychalcone SCHEMBL9542070 | 0.92 | KMT2A (0.96) | F3MAPTRAB9AMAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326839-A1 | TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE INC (US) | 2025-10-23 | — | — | US | claimed |
| US-20250282866-A1 | TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE INC (US) | 2025-09-11 | — | — | US | claimed |
| EP-4255567-A1 | TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS | Vigil Neuroscience, Inc. (US) | 2023-10-11 | — | — | EP | claimed |
| US-20230082623-A1 | TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE, INC. | 2023-03-16 | — | — | US | claimed |
| WO-2022120390-A1 | TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE, INC. (US) | 2022-06-09 | — | — | WO | claimed |
| US-9877946-B2 | Method for treating, managing, inhibiting, or preventing obesity | Research & Business Foundation Sungkyunkwan University (KR) | 2018-01-30 | — | — | US | claimed |
| US-20170087126-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVER SITY (KR) | 2017-03-30 | — | — | US | claimed |
| US-9549908-B2 | Composition for inducing differentiation into beige and brown adipocytes and method of inducing the same | Research & Business Foundation Sungkyunkwan University, Ltd. (KR) | 2017-01-24 | — | — | US | claimed |
| US-20150374643-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2015-12-31 | — | — | US | claimed |
| US-20120070515-A1 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder | EWHA UNIVERSITY- INDUSTRY COLLABORATION FOUNDATION (KR) | 2012-03-22 | — | — | US | claimed |
| US-5342904-A | Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1994-08-30 | — | — | US | claimed |
| US-5248740-A | Thioepoxides, liquid crystal polymers | THE DOW CHEMICAL COMPANY (US) | 1993-09-28 | — | — | US | claimed |
| US-5235008-A | Curable | THE DOW CHEMICAL COMPANY (US) | 1993-08-10 | — | — | US | claimed |
| US-5182340-A | Molding materials having shorter gel time with aliphatic amine curing agents | THE DOW CHEMICAL COMPANY (US) | 1993-01-26 | — | — | US | claimed |
| US-5164464-A | Liquid crystalline polymers, acrylated epoxy resins | THE DOW CHEMICAL COMPANY (US) | 1992-11-17 | — | — | US | claimed |
| US-4962163-A | ADVANCED POLYEPOXIDES AND EPOXY RESINS MODIFIED BY AN UNSATURATED CARBOXYLIC ACID; CURED COATING AND FILMS HAVINGI IMPROVED TENSILE AND FLEXURAL STRENGTH AND MODULUS | THE DOW CHEMICAL COMPANY (US) | 1990-10-09 | — | — | US | claimed |
| EP-0379058-A2 | Vinyl ester resins containing mesogenic/rigid rodlike moieties | THE DOW CHEMICAL COMPANY (US) | 1990-07-25 | — | — | EP | claimed |
| US-4877711-A | DURABLE PRINTING PLATES | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-31 | — | — | US | claimed |
| US-4863835-A | UNSATURATED POLYESTER, BENZYL ALCOHOL, TETRAHYDROFURFURYL ALCOHOL, ACID | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1989-09-05 | — | — | US | claimed |
| US-4279930-A | Process for treating inflammation | THE UPJOHN COMPANY (US) | 1981-07-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170087126-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | FABP4, PLIN1, PRDM7 | F3 3585/4885MAPT 1236/4885RAB9A 4514/4885 |
| US-20150374643-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | FABP4, PLIN1, PRDM7 | F3 3585/4885MAPT 1236/4885RAB9A 4514/4885 |
| US-20120070515-A1 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder | FABP4, ACACB, LIPC | F3 3182/4885MAPT 2597/4885RAB9A 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.